Accelerating BioVenture Innovation (ABI) is a 12-week course and training program in biomedical entrepreneurship. ABI builds teams around patented technologies originating from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and Rockefeller University. The first ABI class is scheduled for Tuesday, August 22. The Kick-off event celebrates the entrepreneurial journey to be undertaken by participants.
Join us at Uris Auditorium to hear from our guest speaker, Erandi De Silva, PhD, Co-Founder and Senior Vice President of Product Development at Forge Biologics, Inc. You will also meet fellow participants and have the opportunity to network with entrepreneurs, peers from neighboring institutions, industry experts, and investors from the NYC ecosystem during a cocktail reception in Griffis Faculty Lounge.
